In March 2025, the company introduced new plans to get a immediate-to-shopper offering of its Wegovy weight loss drug. The company set up a whole new pharmacy, termed NovoCare, which would charge clients $499 a month for access to the drug, below fifty percent the price of the drug by other pharmaceutical distribution networks.[fifty three]Californ